Prion disease treatment is currently making strides that promise hope for patients afflicted by these devastating disorders, including conditions like Creutzfeldt-Jakob disease and fatal familial insomnia.Recent advancements in gene-editing therapy, particularly the innovative base editing technology, have demonstrated potential in targeting the prion protein gene responsible for these ailments.